
Celiac.com 07/30/2025 - This study examined how expectations, rather than the actual presence of gluten, may influence symptoms in people with chronic pain conditions such as fibromyalgia, irritable bowel syndrome, and headaches. By using Open-Label Placebos—pills that patients are told are inactive but may still help—the researchers explored whether changing a person’s mindset could reduce pain and digestive issues during a gluten challenge. The findings suggest that the mind’s role in pain perception may be more significant than previously thought, especially in fibromyalgia.
Why Examine Gluten and Placebos in Chronic Pain?
Many individuals with chronic pain conditions turn to special diets, such as gluten-free eating, in hopes of symptom relief. While some people report benefits, scientific proof has been inconsistent. This study aimed to understand whether the symptoms people report from gluten might be influenced more by what they expect than by what they actually consume. The researchers focused particularly on fibromyalgia, a condition where patients often experience widespread pain without a clear cause, and where food-related symptom triggers are often reported.
How the Study Was Designed
Celiac.com Sponsor (A12):
The study included 26 participants, mainly with fibromyalgia, though some also had chronic headaches or irritable bowel syndrome. Each person took part in a food challenge involving porridge that either did or did not contain gluten. Importantly, participants did not know which version they were eating.
In addition to this food challenge, everyone received a placebo pill. These were called “open-label placebos” because the participants were told the pills had no active ingredients. However, they were given different types of instructions:
- One group received neutral instructions, simply describing the pill.
- Another group received positive instructions, which emphasized that the pill could help relieve symptoms like pain or discomfort.
The researchers then measured changes in participants’ pain levels and digestion before and after eating the porridge.
Key Findings: The Power of Positive Thinking
1. Positive Instructions Reduced Pain in Fibromyalgia Patients
Among people with fibromyalgia, those who were told the placebo might help experienced less pain after eating—even if they consumed actual gluten. Meanwhile, those who received neutral instructions actually reported more pain. This suggests that simply believing a treatment will help can make a real difference in how someone experiences pain.
2. Expectations Predict Outcomes
The link between expectation and outcome was clear: people who expected to feel better were more likely to report pain relief. Those who expected little to no benefit were less likely to improve. This effect was particularly strong in fibromyalgia patients and was less pronounced in those with irritable bowel syndrome or headaches.
3. Placebos Did Not Help with Digestive Symptoms
Interestingly, while the placebos helped reduce pain in some patients, they had no noticeable effect on digestion. Participants still experienced temporary indigestion after the food challenge, whether they consumed gluten or not, and regardless of the type of instruction they received.
4. Gluten Had No Significant Effect
Whether the porridge contained real gluten or not didn’t make a difference in pain or digestion outcomes. This suggests that the idea of gluten might be more powerful than gluten itself for some individuals. People may be experiencing a “nocebo effect”—a negative reaction caused by the belief that something will harm them, even if it doesn’t.
Exploring the Role of Placebo in Different Conditions
The study included people with three different types of chronic pain:
- Fibromyalgia: These patients seemed most responsive to the expectation-based intervention. Since they experience chronic pain that isn’t caused by physical damage, their symptoms may be particularly sensitive to psychological and emotional factors like expectation and belief.
- Irritable Bowel Syndrome: Patients with irritable bowel syndrome didn’t show significant pain changes. Some may not have had symptoms when the study began, making it harder to detect improvements. IBS and fibromyalgia share features like heightened sensitivity and fatigue, but the placebo effect was weaker in IBS participants.
- Chronic Headache: All patients with headaches experienced a reduction in pain, regardless of the presence of gluten or type of placebo instruction. However, due to the small number of participants in this group, the findings were considered exploratory and not conclusive.
Why This Study Matters for Celiac Disease and Gluten Sensitivity
Although this study did not include participants with celiac disease, its findings may still resonate with people who suspect they have gluten sensitivity but do not test positive for celiac. Many such individuals report gluten-related symptoms despite no medical confirmation of intolerance. This research shows that expectations may play a larger role than previously thought in how gluten affects the body—at least when it comes to pain.
For those with confirmed celiac disease, this study does not suggest that eating gluten is safe. Celiac disease is an autoimmune condition where gluten causes damage to the small intestine, and strict gluten avoidance remains essential. However, for people without celiac disease but who feel worse after eating gluten, it raises the possibility that psychological mechanisms like expectation and belief may be contributing to symptoms.
The Role of Open-Label Placebos
This study adds to the growing body of research showing that placebos can help—even when people know they are taking a placebo. This makes the treatment ethical and transparent, especially when used alongside other care. Open-label placebos could offer a safe, drug-free option for people with chronic pain, helping them gain some relief without side effects.
Interestingly, the study also shows that the way information is delivered—whether instructions are positive or neutral—can significantly change how people feel. This emphasizes the importance of how healthcare providers communicate with patients.
Conclusion: Shifting the Focus from Gluten to the Mind
This study suggests that for some people with chronic pain, particularly fibromyalgia, the belief that gluten causes harm may be more powerful than gluten itself. Pain perception was significantly influenced by expectations, especially when those expectations were shaped positively. While open-label placebos did not reduce digestive symptoms, they did reduce pain in some cases.
These findings do not invalidate real experiences of pain or discomfort after eating gluten. Instead, they open the door to new, more holistic approaches that combine diet, psychological care, and expectation management. For people navigating gluten sensitivity without a celiac diagnosis, this research suggests that the brain’s role in pain and symptom development deserves more attention—and may hold the key to better outcomes.
Read more at: frontiersin.org
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now